Erythematotelangiectatic or papulopustular rosacea. Rosacea
Conditions
Interventions
Intervention 1: Intervention group 1: Treatment with metronidazole gel 0.75% once per night for 3 months. For this purpose, the patient uses a thin layer of metronidazole gel locally on his/her erythe
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 50 Years
Inclusion criteria
Inclusion criteria: Patients aged 15 to 50 years Patients with a confirmed diagnosis of erythematotelangiectatic or papulopustular rosacea or a combination of both The patient has not received treatment for his or her disease in the past two months Absence of a serious underlying disease Patient's cooperation in the implementation of therapeutic measures and participation in all therapeutic sessions
Exclusion criteria
Exclusion criteria: The occurrence of a sensitivity or adverse reaction to any of the therapeutic agents that prevents continuation of treatment The occurrence of bacterial or viral skin disease during treatment or the follow-up period
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluating the severity of the disease. Timepoint: One, two, three and five months after starting treatment. Method of measurement: By the total severity score of rosacea. | — |
Secondary
| Measure | Time frame |
|---|---|
| Doctor and patient satisfaction. Timepoint: One, two, three and five months after starting treatment. Method of measurement: Caregiver treatment satisfaction (CTS) questionnaire scale.;Safety. Timepoint: One, two, three and five months after starting treatment. Method of measurement: Examining the side effects of the treatment with a questionnaire.;Tolerability. Timepoint: One, two, three and five months after starting treatment. Method of measurement: with the Investigator Assessment of Tolerability scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAfsaneh Sadeghzadeh bazargan
Iran University of Medical Sciences
Outcome results
None listed